GlassScriptPhysician profile
Steven Lewis
NPI 1538519467
$22,082.09
in general payments reported to CMS, 2019-2025
12 companies · $556 in 2025
The $556 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,028 · 2020: $274 · 2021: $5,870 · 2022: $10K · 2023: $3,503 · 2024: $382 · 2025: $556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,866 · Travel and Lodging: $1,575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,866.12 |
| Travel and Lodging | $1,574.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $10,500.00 | 2021-2022 | |
| Medwest Associates | $4,323.84 | 2019-2023 | |
| Stryker Corporation | $3,176.16 | 2022-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform, Aequalis Perform Reversed |
| Arthrex, INC. | $1,909.07 | 2022-2025 | Arthrex |
| Zimmer Biomet Holdings, INC. | $1,398.82 | 2019-2024 | Rosa, Tapestry, Comprehensive Shoulder System |
| Medical Device Business Services, INC. | $522.34 | 2019-2020 | |
| Shoulder Innovations, INC. | $166.03 | 2023 | Inset System |
| Abbott Laboratories | $22.70 | 2025 | Proclaim |
| Davol INC. | $20.26 | 2025 | Arista |
| Linvatec Corporation | $15.94 | 2024 | Biobrace 23mm |
| Ferring Pharmaceuticals INC. | $14.86 | 2022 | |
| Depuy Synthes Sales INC. | $12.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.